V. Papademetriou

发表

Jackson T. Wright, P. Whelton, K. Sink, 2017, Journal of the American Society of Nephrology : JASN.

Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.

G. Parati, C. Tsioufis, C. Stefanadis, 2015, International journal of cardiology.

Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis

C. Tsioufis, V. Papademetriou, D. Tousoulis, 2017, Journal of hypertension.

Change in Systolic Left Ventricular Performance After 3 Years of Antihypertensive Treatment: The Losartan Intervention for Endpoint (LIFE) Study

M. Nieminen, G. Aurigemma, R. Devereux, 2002, Circulation.

Physicians' Perceptions and Adherence to Guidelines for the Management of Hypertension: A National, Multicentre, Prospective Study

V. Papademetriou, N. Maniadakis, G. Kourlaba, 2012, International journal of hypertension.

Joint ESH Excellence Centers' National Meeting on Renal Sympathetic Denervation: a Greek Experts' Survey.

A. Triantafyllou, C. Tsioufis, V. Papademetriou, 2021, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Alcohol-mediated renal sympathetic neurolysis for the treatment of hypertension: The Peregrine™ infusion catheter.

R. Schmieder, S. Bertog, D. Kandzari, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Blood Pressure Control Among US Veterans: A Large Multiyear Analysis of Blood Pressure Data From the Veterans Administration Health Data Repository

Ronald E. Jones, V. Papademetriou, P. Kokkinos, 2012, Circulation.

Is It Time to Treat Prehypertension?

V. Papademetriou, D. Papadopoulos, T. Makris, 2008, Hypertension Research.

Diuretics, Hypokalemia, and Cardiac Arrhythmia: A 20‐Year Controversy

V. Papademetriou, 2006, Journal of clinical hypertension.

From Hypertension to Heart Failure

V. Papademetriou, 2004, Journal of clinical hypertension.

Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).

A. Hofman, A. Zanchetti, V. Papademetriou, 2004, Journal of the American College of Cardiology.

Analysis of T-Wave Morphology From the 12-Lead Electrocardiogram for Prediction of Long-Term Prognosis in Male US Veterans

Katerina Hnatkova, Marek Malik, Markus Zabel, 2002, Circulation.

Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.

J. Gottdiener, G. Chase, V. Papademetriou, 1997, Journal of the American College of Cardiology.

Renal Sympathetic Denervation: Hibernation or Resurrection?

C. Tsioufis, V. Papademetriou, M. Doumas, 2016, Cardiology.

Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension.

V. Papademetriou, 2009, The American journal of cardiology.

Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial

J. Williamson, D. Berlowitz, D. Kitzman, 2017, JAMA internal medicine.

Metabolic Side Effects and Cardiovascular Events of Diuretics: Should a Diuretic Remain the First Choice Therapy in Hypertension Treatment? The Case of Yes

V. Papademetriou, D. Papadopoulos, 2007, Clinical and experimental hypertension.

Place of Invasive Procedures in Blood Pressure Control

C. Tsioufis, V. Papademetriou, A. Kasiakogias, 2018 .

Carotid Baroreceptor Activation for the Treatment of Resistant Hypertension and Heart Failure

C. Tsioufis, V. Papademetriou, C. Faselis, 2012, Current Hypertension Reports.

Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2011, International journal of hypertension.

Metoprolol Succinate Combination in the Treatment of Hypertension

V. Papademetriou, D. Papadopoulos, 2009, Angiology.

Resistant Hypertension: Diagnosis and Management

V. Papademetriou, D. Papadopoulos, 2006, Journal of cardiovascular pharmacology and therapeutics.

The Study on COgnition and Prognosis in the Elderly (SCOPE) – Major CV events and stroke in subgroups of patients

A. Hofman, A. Zanchetti, V. Papademetriou, 2005, Blood pressure.

Current Drug Treatment and Treatment Patterns with Antihypertensive Drugs

E. Freis, V. Papademetriou, 1996, Drugs.

Pharmacological Management of Diabetic Nephropathy.

V. Papademetriou, C. Papadopoulos, K. Tsioufis, 2020, Current vascular pharmacology.

Effects of moderate intensity exercise on serum lipids in African-American men with severe systemic hypertension.

V. Papademetriou, P. Kokkinos, R. Fletcher, 1998, The American journal of cardiology.

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

P. Whelton, G. Stone, G. Parati, 2022, Circulation.

Now That Renal Denervation Works, How Do We Proceed?

V. Papademetriou, M. Doumas, K. Tsioufis, 2019, Circulation research.

New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension

C. Tsioufis, R. Schmieder, V. Papademetriou, 2019, International Journal of Cardiology. Hypertension.

Serial changes in vessel walls of renal arteries after catheter-based renal artery denervation: insights from volumetric computed tomography analysis

C. Tsioufis, V. Papademetriou, S. Nicholls, 2018, International journal of nephrology and renovascular disease.

Erratum to: Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry

P. Vardas, I. Kallikazaros, C. Tsioufis, 2017, Clinical Research in Cardiology.

Renal sympathetic denervation resurrected; or NOT?

V. Papademetriou, 2017 .

SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies.

C. Tsioufis, V. Papademetriou, D. Tousoulis, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry

P. Vardas, I. Kallikazaros, C. Tsioufis, 2016, Clinical Research in Cardiology.

Renal Denervation: Back to the Future?

V. Papademetriou, V. Raman, P. Chrysostomou, 2015 .

Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.

C. Tsioufis, V. Papademetriou, M. Doumas, 2014, Circulation.

Renal Nerve Ablation for Resistant Hypertension: The Dust Has Not Yet Settled

V. Papademetriou, M. Doumas, A. Lazaridis, 2014, Journal of clinical hypertension.

Catheter-Based Renal Denervation for Resistant Hypertension: 12-Month Results of the EnligHTN I First-in-Human Study Using a Multielectrode Ablation System

C. Tsioufis, I. Meredith, V. Papademetriou, 2014, Hypertension.

Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom).

C. Tsioufis, V. Papademetriou, M. Doumas, 2014, Circulation research.

Catheter-based renal sympathetic denervation exerts acute and chronic effects on renal hemodynamics in swine.

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2013, International journal of cardiology.

Impressive Blood Pressure and Heart Rate Response After Percutaneous Renal Denervation in a Woman With Morbid Obesity and Severe Drug‐Resistant Hypertension

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2013, Journal of clinical hypertension.

Renal sympathetic denervation in hypertension

V. Papademetriou, C. Faselis, M. Doumas, 2011, The Medical letter on drugs and therapeutics.

Baroreflex activation therapy and resistant hypertension randomization is not enough, you should measure blood pressure appropriately.

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2012, Journal of the American College of Cardiology.

β-blockers in the management of hypertension: focus on nebivolol

V. Papademetriou, D. Wojciechowski, 2008, Expert review of cardiovascular therapy.

Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil

V. Papademetriou, R. Lakshman, P. Narayan, 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.

G. Aurigemma, R. Devereux, J. Bella, 2004, American heart journal.

From hypertension to heart failure: breaking the chain of cardiovascular disease

V. Papademetriou, 2003 .

Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment

R. Devereux, J. Bella, V. Palmieri, 2002 .

Hypertension and cognitive function. Blood pressure regulation and cognitive function: a review of the literature.

V. Papademetriou, 2005, Geriatrics.

Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study)

M. Nieminen, R. Devereux, V. Papademetriou, 2009, Blood pressure.

and Future Directions Renal Nerve Ablation for Resistant Hypertension : How Did We Get Here

C. Tsioufis, V. Papademetriou, M. Doumas, 2014 .

On Target to Dual Block RAS?

V. Papademetriou, D. Papadopoulos, T. Makris, 2009, Angiology.

Losartan in cardiovascular disease.

V. Papademetriou, E. Hoorn, S. de Vogel, 2005, Future cardiology.

The potential role of AT1-receptor blockade in the prevention and reversal of atherosclerosis

V. Papademetriou, 2002, Journal of Human Hypertension.

Echocardiographic assessment by computer-assisted analysis of diastolic left ventricular function and hypertrophy in borderline or mild systemic hypertension.

E. Freis, J. Gottdiener, V. Papademetriou, 1985, The American journal of cardiology.

Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension.

I. Kallikazaros, C. Tsioufis, P. Toutouzas, 2005, The American journal of cardiology.

Targeting angiotensin II type I receptors to reduce the risk of stroke in patients with hypertension

V. Papademetriou, D. Papadopoulos, 2006, Expert opinion on therapeutic targets.

Effect of diuretic therapy on ventricular arrhythmias in hypertensive patients with or without left ventricular hypertrophy.

E. Freis, J. Gottdiener, V. Papademetriou, 1985, American heart journal.

Candesartan cilexetil in cardiovascular disease

V. Papademetriou, A. Ross, 2004, Expert review of cardiovascular therapy.

Severity of coronary artery disease in black and white male veterans and likelihood of revascularization.

V. Papademetriou, R. Fletcher, D. Lu, 2000, American heart journal.

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study

M. Nieminen, P. Okin, R. Devereux, 2002, Journal of hypertension.

Evaluation and Treatment of Resistant or Difficult‐to‐Control Hypertension

V. Papademetriou, R. Fletcher, D. Wojciechowski, 2008, Journal of clinical hypertension.

Exercise Physiology Exercise Capacity and Mortality in Older Men

D. Panagiotakos, V. Papademetriou, P. Kokkinos, 2010 .

Effects of diltiazem, metoprolol, enalapril and hydrochlorothiazide on frequency of ventricular premature complexes.

V. Papademetriou, P. Kokkinos, P. Narayan, 1994, The American journal of cardiology.

Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (from the ACCORD Study)

E. Soliman, C. Tsioufis, J. Basile, 2015 .

Left Ventricular Hypertrophy and Mortality Risk in Male Veteran Patients at High Cardiovascular Risk.

C. Tsioufis, V. Papademetriou, P. Kokkinos, 2020, The American journal of cardiology.

Geometric patterns of left ventricular hypertrophy: Is geometry alone to be blamed?

V. Papademetriou, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Left ventricular mass regression in the LIFE study: effect of previous antihypertensive treatment.

M. Nieminen, G. Aurigemma, R. Devereux, 2003, American journal of hypertension.

Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.

Jackson T. Wright, R. Devereux, K. Borch-Johnsen, 2002, American heart journal.

R. Devereux, J. Bella, V. Papademetriou, 2001, American journal of hypertension.

Effect of hydrochlorothiazide therapy on cardiac arrhythmias in African-American men with systemic hypertension and moderate to severe left ventricular hypertrophy.

V. Papademetriou, P. Narayan, 1996, The American journal of cardiology.

Abstract 19523: Catheter-Based Renal Denervation for the Treatment of Patients with Drug-Resistant Hypertension: EnligHTN I: Three-Month Data of a First in Man Study Using a Multi-Electrode Radiofrequency Ablation Catheter

C. Tsioufis, I. Meredith, V. Papademetriou, 2012 .

Renal Fibromuscular Dysplasia: A Not So Common Entity of Secondary Hypertension

V. Papademetriou, E. Sanidas, D. Papadopoulos, 2016, Journal of clinical hypertension.

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.

W. Cushman, W. Applegate, V. Papademetriou, 2015, Kidney international.

Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus

V. Papademetriou, G. Lessey, K. Stavropoulos, 2019, Vascular health and risk management.

Exceptional early blood pressure control rates: The ACCOMPLISH trial

W. Cushman, G. Bakris, B. Pitt, 2007, Blood pressure.

Protective Effects of Angiotensin‐Converting Enzyme Inhibitors in High‐Risk African American Men With Coronary Heart Disease

V. Papademetriou, P. Kokkinos, C. Faselis, 2009, Journal of clinical hypertension.

Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study

C. Tsioufis, V. Papademetriou, D. Tousoulis, 2018, Journal of Human Hypertension.

Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study

G. Bakris, I. Kallikazaros, C. Tsioufis, 2014, Journal of hypertension.

Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2011, Expert opinion on therapeutic targets.

Treatmentstrategiestoprevent stroke:focusonoptimallipidand bloodpressurecontrol

V. Papademetriou, M. Doumas, 2009 .

Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

B. Davis, S. Oparil, W. Cushman, 2012, Hypertension.

The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction.

V. Papademetriou, K. Imprialos, K. Stavropoulos, 2019, Current pharmaceutical design.

Primary aldosteronism: novel insights.

V. Papademetriou, M. Doumas, K. Tsioufis, 2020, Current hypertension reviews.

Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension.

E. Freis, V. Papademetriou, M. Price, 1984, The American journal of cardiology.

Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

Deepak L. Bhatt, D. Kandzari, J. Davies, 2014, International journal of cardiology.

Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study).

R. Devereux, J. Bella, V. Palmieri, 2002, The American journal of cardiology.

Non-interventional management of resistant hypertension.

C. Tsioufis, V. Papademetriou, M. Doumas, 2014, World journal of cardiology.

Eulogy for Edward D. Freis, MD*

V. Papademetriou, 2005 .

Left Ventricular Wall Stress–Mass–Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study

M. Nieminen, R. Devereux, V. Palmieri, 2015, Hypertension.

Association of Hemoglobin Delivery With Left Ventricular Structure and Function in Hypertensive Patients: Losartan Intervention For End Point Reduction in Hypertension Study

M. Nieminen, R. Devereux, G. de Simone, 2006, Hypertension.

Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study

M. Nieminen, R. Devereux, J. Bella, 2004, Journal of Human Hypertension.

Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study.

M. Nieminen, P. Okin, M. Viitasalo, 2003, American heart journal.

Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study

M. Nieminen, R. Devereux, J. Bella, 2003, Journal of hypertension.

Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study

M. Nieminen, R. Devereux, J. Bella, 2002, Journal of hypertension.

Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).

R. Devereux, V. Palmieri, V. Papademetriou, 2002, The American journal of cardiology.

Echocardiographic Left Ventricular Geometry in Hypertensive Patients with Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study

M. Nieminen, P. Okin, R. Devereux, 2001, Blood pressure.

Drug-resistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden

I. Kallikazaros, C. Tsioufis, C. Stefanadis, 2014, Journal of Human Hypertension.

Implantation of a Carotid Baroreceptor Stimulator in Patients with Pacemakers and Hypertension

E. Irwin, S. Muluk, V. Papademetriou, 2011, Pacing and clinical electrophysiology : PACE.

Drug therapy for the patient with resistant hypertension.

M. Böhm, V. Papademetriou, F. Mahfoud, 2015, Future cardiology.

Diuretics, hypokalemia, and cardiac arrhythmias: a critical analysis.

V. Papademetriou, 1986, American heart journal.

Polycythemia hypertonica revisited: a metabolic syndrome with high-renin hypertension?

V. Papademetriou, D. Vlahakos, Vassilios Vlahakos, 2022, Journal of Human Hypertension.

Insomnia and hypertension: A misty landscape

V. Papademetriou, M. Doumas, K. Imprialos, 2019, Journal of clinical hypertension.

How Dangerous Are Diuretics?

E. Freis, V. Papademetriou, 1985, Drugs.

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in African‐American Patients With Hypertension

V. Papademetriou, P. Kokkinos, P. Narayan, 2004, Journal of clinical hypertension.

Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2010, Journal of hypertension.

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

M. Nieminen, G. Aurigemma, R. Devereux, 2010, Journal of hypertension.

Changes in Structure and Function of the Left Ventricle in the Hypertension Syndrome

V. Papademetriou, P. Kokkinos, Vasilios Papademetriou, 1997, Journal of cardiovascular risk.

Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.

V. Papademetriou, J. Sugg, J. Hainer, 2006, American journal of hypertension.

Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).

G. Aurigemma, J. Bella, V. Palmieri, 2010, The American journal of cardiology.

Expertise: No Longer a Sine Qua Non for Guideline Authors?

K. Kario, G. Parati, G. Mancia, 2017, Hypertension.

Response to Letter Regarding Article, “Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)”

B. Davis, J. Cutler, M. Proschan, 2006 .

Hypertensive urgencies during the first wave of the COVID-19 pandemic in a tertiary hospital setting: a U-shaped alarming curve

M. Banach, V. Papademetriou, G. Tsivgoulis, 2021, Archives of medical science : AMS.

Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study

J. Gardin, M. Nieminen, R. Devereux, 2008, Journal of hypertension.

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408

M. Feinglos, V. Papademetriou, A. Bress, 2018, Diabetes Care.

Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?

V. Papademetriou, M. Doumas, N. Katsiki, 2018, Angiology.

Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk: A LIFE Substudy

R. Devereux, S. Kjeldsen, V. Papademetriou, 2005, HYPERTENSION.

P-376: Left ventricular mass change during treatment and outcome in hypertensive patients with left ventricular hypertrophy: the LIFE trial

M. Nieminen, R. Devereux, V. Papademetriou, 2002 .

Prognostic significance of left ventricular hypertrophy during treatment of hypertension: The LIFE study

M. Nieminen, R. Devereux, S. Snapinn, 2003 .

Human Immunodeficiency Virus Infection And Hypertension. Is There a Connection?

V. Papademetriou, E. Sanidas, D. Papadopoulos, 2018, American journal of hypertension.

Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.

G. Parati, C. Tsioufis, C. Stefanadis, 2015, International journal of cardiology.

Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations

C. Tsioufis, V. Papademetriou, D. Tousoulis, 2019, Journal of clinical hypertension.

Expertise: no longer a sine qua non for guideline authors?

K. Kario, G. Parati, G. Mancia, 2017, Journal of hypertension.

Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study).

M. Nieminen, R. Devereux, V. Papademetriou, 2005, The American journal of cardiology.

Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment.

V. Papademetriou, M. Weir, M. Weber, 1995, American heart journal.

Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy.

V. Papademetriou, N. Katsiki, M. Doumas, 2014, Current pharmaceutical design.

Nonsustained Ventricular Tachycardia as a Predictor of Cardiovascular Events in Black Men With Hypertensive Left Ventricular Hypertrophy.

V. Papademetriou, P. Kokkinos, P. Narayan, 2000, Journal of clinical hypertension.

Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model

M. Böhm, V. Papademetriou, A. Pathak, 2016, Journal of hypertension.

Acute and Short‐Term Effects of a New Calcium Antagonist in Hypertension

E. Freis, V. Papademetriou, J. Burris, 1982, Hypertension.

Blood Pressure Intervention and Control in SPRINT

Jackson T. Wright, P. Whelton, S. Oparil, 2022, Hypertension.

Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle

V. Papademetriou, C. Loutradis, C. Papadopoulos, 2022, The International Journal of Cardiovascular Imaging.

Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing.

C. Tsioufis, C. Stefanadis, D. Tousoulis, 2012, The American journal of cardiology.

Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2013, Journal of Human Hypertension.

Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.

V. Papademetriou, M. Doumas, Daqing Guo, 2009, Expert opinion on therapeutic targets.

Non-dipping of blood pressure during sleep does not predict awake or exercise hemodynamics. The Zilot study.

V. Papademetriou, P. Kokkinos, J. Neutel, 1999 .

Cardiorespiratory fitness and coronary heart disease risk factor association in women.

J. Holland, V. Papademetriou, P. Kokkinos, 1995, Journal of the American College of Cardiology.

Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control

P. Whelton, Mahboob Rahman, W. Cushman, 2018, Circulation.

Prognostic relevance of visit‐to‐visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions?

Jackson T. Wright, P. Whelton, D. Reboussin, 2018, The Journal of Clinical Hypertension.

Screening for Primary Aldosteronism: Whom and How?

V. Papademetriou, V. Athyros, M. Doumas, 2015, Journal of clinical hypertension.

Exercise Capacity and Mortality in Black and White Men Exercise Physiology

V. Papademetriou, P. Kokkinos, A. Manolis, 2008 .

Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.

S. Steinberg, S. Libutti, W. Linehan, 2010, Journal of the American College of Surgeons.

Left ventricular hypertrophy: not so much determinant of renal outcome?

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2011, Journal of hypertension.

Renal Sympathetic Denervation in Isolated Systolic Hypertension.

C. Tsioufis, V. Papademetriou, M. Doumas, 2019, Hypertension.

Diuretics in hypertension: clinical experiences.

V. Papademetriou, 1992, European heart journal.

Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril

Barry R. Davis, L. Julian Haywood, Charles E. Ford, 2005 .

Electrocardiographic abnormalities suggestive of myocardial ischemia during upper gastrointestinal bleeding.

V. Papademetriou, R. Fletcher, P. Narayan, 1995, The American journal of cardiology.

Hypertrophic and Hypertensive Hypertrophic Cardiomyopathy—A True Association?

V. Papademetriou, D. Papadopoulos, 2010, Angiology.

Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study.

M. Nieminen, P. Okin, M. Viitasalo, 2001, Journal of hypertension.

Cardiovascular Safety of Triptans

V. Papademetriou, D. Dodick, D. Dodick, 2004, Cephalalgia : an international journal of headache.

Regional cardiac compression due to a large anaerobic bacterial empyema

V. Papademetriou, R. Fletcher, M. Ballo, 1996, Clinical cardiology.

Who is an expert? Reply

K. Kario, G. Parati, G. Mancia, 2017 .

Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention

Deepak L. Bhatt, Sunil V. Rao, K. Shunk, 2020, Circulation. Cardiovascular interventions.

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

B. Davis, Jackson T. Wright, J. Cutler, 2002, Journal of clinical hypertension.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Effectiveness of potassium chloride or triamterene in thiazide hypokalemia.

E. Freis, V. Papademetriou, J. Burris, 1985, Archives of internal medicine.

Controversy in Hypertension: Are Diuretics Harmful?

E. Freis, V. Papademetriou, 1985 .

Well and accurately taken office blood pressure measurements, automated or auscultatory, should still remain the standard of care

V. Papademetriou, 2020 .

Electrical stimulation of the renal arterial nerves does not unmask the blindness of renal denervation procedure in swine.

C. Tsioufis, C. Stefanadis, D. Tousoulis, 2014, International journal of cardiology.

Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation.

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2014, Current vascular pharmacology.

The role of exercise in the control of hypertension and cardiovascular risk.

V. Papademetriou, P. Kokkinos, 1996, Current opinion in nephrology and hypertension.

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

R. Devereux, J. Bella, M. Roman, 2000, Hypertension.

Left ventricular geometry and function in hypartensive patients with ECG left ventricular hypertrophy: the LIFE trial

R. Devereux, J. Bella, V. Papademetriou, 1998 .

Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle

V. Papademetriou, C. Loutradis, C. Papadopoulos, 2022, The International Journal of Cardiovascular Imaging.

Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies

V. Papademetriou, A. Gradman, K. Tsioufis, 2011, International journal of hypertension.

Antihypertensive Drug Therapy and Erectile Dysfunction

V. Papademetriou, M. Doumas, Eirini Papadopoulou, 2015 .

Treatment strategies to prevent stroke: focus on optimal lipid and blood pressure control

V. Papademetriou, M. Doumas, 2009 .

Prognostic significance of left ventricular mass change during treatment of hypertension.

M. Nieminen, R. Devereux, V. Papademetriou, 2004, JAMA.

Exercise as hypertension therapy.

V. Papademetriou, P. Kokkinos, P. Narayan, 2001, Cardiology clinics.

Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

W. Cushman, M. Proschan, K. Margolis, 2001, Hypertension.

Exercise and hypertension.

V. Papademetriou, P. Kokkinos, Peter Kokkinos, 2000, Coronary artery disease.

Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias.

E. Freis, V. Papademetriou, R. Fletcher, 1983, The American journal of cardiology.

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

Laura Lovato, W. Cushman, W. Applegate, 2016, American Journal of Nephrology.

Revival of Renal Denervation Therapy for Hypertension: Real Hope or just a Dream?

V. Papademetriou, V. Raman, 2016 .

Microalbuminuria is associated with unfavourable cardiac geometric adaptations in essential hypertensive subjects

I. Kallikazaros, C. Tsioufis, C. Stefanadis, 2002, Journal of Human Hypertension.

The Impact of Various Blood Pressure Measurements on Cardiovascular Outcomes.

V. Papademetriou, C. Papadopoulos, K. Stavropoulos, 2020, Current vascular pharmacology.

Home, automated office, and conventional office blood pressure as predictors of cardiovascular risk.

V. Papademetriou, K. Aronis, G. Kolyvas, 2017, Journal of the American Society of Hypertension : JASH.

Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial)

P. Whelton, D. Reboussin, W. Cushman, 2017, Hypertension.

A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support.

V. Papademetriou, E. Geladari, H. Moore, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial.

J. Fleg, L. Chen, J. Bigger, 2016, American journal of hypertension.

Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.

M. Rocco, S. Oparil, E. Soliman, 2019, Hypertension.

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).

D. Goff, W. Cushman, E. Soliman, 2014, The American journal of cardiology.

Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study

M. Nieminen, R. Devereux, V. Papademetriou, 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

P. Whelton, M. Rocco, P. Kimmel, 2019, Journal of the American Society of Nephrology : JASN.

Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.

E. Michelson, S. Nesbitt, S. Julius, 2005, American journal of hypertension.

Benefits from Treatment and Control of Patients with Resistant Hypertension

S. Douma, V. Papademetriou, K. Petidis, 2010, International journal of hypertension.

Treatment of severe hypertension with intravenous labetalol

E. Freis, V. Papademetriou, I. Khatri, 1982, Clinical pharmacology and therapeutics.

The VA Co-operative Studies; The First RCTs in Cardiovascular Disease – A Tribute to Edward D. Freis

C. Tsioufis, V. Papademetriou, K. Dimitriadis, 2018, Management of Hypertension.

Renal Denervation: A Historical Perspective

C. Tsioufis, V. Papademetriou, V. Raman, 2016 .

Sympathetic Renal Denervation Using the EnligHTN Multi-electrode Ablation System: The St Jude Experience

C. Tsioufis, V. Papademetriou, M. Doumas, 2015 .

Consensus Statement: Cardiovascular Safety Profile of Triptans (5‐HT1B/1D Agonists) in the Acute Treatment of Migraine

S. Hahn, R. Lipton, K. Welch, 2004, Headache.

Hypertension and Atherosclerosis: Pathophysiology, Mechanisms and Benefits of BP Control

V. Papademetriou, P. Chrysostomou, Misbah S. Zaheer, 2016 .

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension

V. Papademetriou, K. Tsioufis, M. Doumas, 2011, International journal of hypertension.

Renal sympathetic denervation and systemic hypertension.

V. Papademetriou, M. Doumas, Charles Faselis, 2010, The American journal of cardiology.

Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.

T. Craven, F. Ismail-Beigi, R. Sigal, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Gender Differences in Hypertension: Myths and Reality

V. Papademetriou, P. Kokkinos, M. Doumas, 2013, Current Hypertension Reports.

Inhibition of the renin-angiotensin system in the cardiorenal syndrome with anaemia: a double-edged sword.

G. Filippatos, G. Mancia, C. Tsioufis, 2019, Journal of hypertension.

Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.

V. Papademetriou, A. Gradman, 2009, American heart journal.

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Barry R Davis, B. Davis, P. Whelton, 2005, JAMA.

Effect of Intensive Versus Standard Blood Pressure Control on Stroke Subtypes

S. Oparil, W. Ambrosius, A. Auchus, 2021, Hypertension.

Time in Therapeutic Range, as a Determinant of All‐Cause Mortality in Patients With Hypertension

C. Tsioufis, V. Papademetriou, R. Amdur, 2017, Journal of the American Heart Association.

Exercise Capacity and Progression From Prehypertension to Hypertension

D. Panagiotakos, V. Papademetriou, P. Kokkinos, 2012, Hypertension.

Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.

V. Papademetriou, 2009, American heart journal.

National Utilization of Antihypertensive Medications From 2000 to 2006 in the Veterans Health Administration: Focus on Thiazide Diuretics

W. Cushman, D. Berlowitz, P. Glassman, 2008, Journal of clinical hypertension.

Aggressive blood pressure control and stroke prevention: role of calcium channel blockers

V. Papademetriou, D. Papadopoulos, 2008, Journal of hypertension.

Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

B. Davis, J. Cutler, M. Proschan, 2006, Circulation.

Miles run per week and high-density lipoprotein cholesterol levels in healthy, middle-aged men. A dose-response relationship.

J. Holland, V. Papademetriou, P. Kokkinos, 1995, Archives of internal medicine.

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.

J. Wittes, L. Wexler, P. Deedwania, 2001, JAMA.

Efficacy and safety of pravastatin in African Americans with primary hypercholesterolemia.

V. Papademetriou, J. Larosa, V. Miller, 1995, Archives of internal medicine.

Chapter 56 – Management of Associated Cardiovascular Risk in Essential Hypertension

V. Papademetriou, 2008 .

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

P. Whelton, M. Rocco, Mahboob Rahman, 2017, Annals of internal medicine.

Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

Anne L. Taylor, M. Nieminen, P. Okin, 2002, American journal of hypertension.

Characteristics and Lipid Distribution of a Large, High‐Risk, Hypertensive Population: The Lipid‐Lowering Component of the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

D. Gordon, N. Wong, L. Haywood, 2003, Journal of clinical hypertension.

Heart rate recovery, exercise capacity, and mortality risk in male veterans

J. Myers, V. Papademetriou, P. Kokkinos, 2012, European journal of preventive cardiology.

Exercise capacity and mortality in older men: a 20-year follow-up study.

Demosthenes B Panagiotakos, Athanasios Manolis, D. Panagiotakos, 2010, Circulation.

Exercise Capacity and Mortality in Black and White Men

J. Myers, V. Papademetriou, P. Kokkinos, 2008, Circulation.

Air pollution and arterial hypertension. A new risk factor is in the air.

Elias Sanidas, V. Papademetriou, E. Sanidas, 2017, Journal of the American Society of Hypertension : JASH.

Comparative prognostic value of systolic, diastolic, and pulse pressure.

V. Papademetriou, 2003, The American journal of cardiology.

Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome

G. Grassi, C. Tsioufis, V. Papademetriou, 2017, Journal of hypertension.

APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial

M. Rocco, P. Kimmel, B. Freedman, 2017, Kidney international reports.

Common Secondary Causes of Resistant Hypertension and Rational for Treatment

V. Papademetriou, M. Doumas, C. Faselis, 2011, International journal of hypertension.

Chronic heart failure and exercise.

S. Ellahham, V. Papademetriou, P. Kokkinos, 2000, American heart journal.

Ramiprilof its Use in the Prevention of Cardiovascular Outcomes

W. Aronow, N. Sharpe, V. Papademetriou, 2002 .

Albuminuria and cognitive decline in people with diabetes and normal renal function.

J. Williamson, A. Murray, J. Lovato, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Selecting Optimum Antihypertensive Therapy

V. Papademetriou, M. Doumas, 2016 .

Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

M. Nieminen, R. Devereux, V. Papademetriou, 2004, Circulation.

Unobserved automated office BP is similar to other clinic BP measurements: A prospective randomized study

C. Tsioufis, V. Papademetriou, C. Geladari, 2018, Journal of clinical hypertension.

Attended and Unattended Automated Office Blood Pressure Measurements Have Better Agreement With Ambulatory Monitoring Than Conventional Office Readings

V. Papademetriou, C. Geladari, E. Andreadis, 2018, Journal of the American Heart Association.

Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study

V. Palmieri, V. Papademetriou, B. Dahlöf, 2004, Journal of Human Hypertension.

Left ventricular wall stresses and wall stress–mass–heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study

Richard B. Devereux, Mary J. Roman, Vittorio Palmieri, 2000 .

Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension.

V. Papademetriou, M. Weir, J. Neutel, 1998, The American journal of cardiology.

Apelin and Relaxin Plasma Levels in Young Healthy Offspring of Patients With Essential Hypertension

C. Tsioufis, V. Papademetriou, D. Perrea, 2014, Journal of clinical hypertension.

Body mass index, exercise capacity, and mortality risk in male veterans with hypertension.

D. Panagiotakos, C. Tsioufis, V. Papademetriou, 2012, American journal of hypertension.

Does rapidity of blood pressure lowering affect outcomes in hypertension treatment?

V. Papademetriou, D. Wojciechowski, 2008 .

Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks.

K. Ferdinand, V. Papademetriou, W. Hall, 1999, Journal of the National Medical Association.

Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension.

D. Reda, V. Papademetriou, P. Kokkinos, 1995, The New England journal of medicine.

Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.

M. Rocco, W. Cushman, L. Tamariz, 2020, Journal of hypertension.

Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed.

G. Stergiou, V. Papademetriou, M. Doumas, 2016, Journal of the American Society of Hypertension : JASH.

Improvement in All‐Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug‐Resistant Hypertension

V. Papademetriou, P. Kokkinos, C. Faselis, 2016, Journal of clinical hypertension.

Sodium-Glucose Cotransporter-2 Inhibitors, Reverse J-Curve Pattern, and Mortality in Heart Failure.

V. Papademetriou, K. Imprialos, K. Stavropoulos, 2019, Heart failure clinics.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

S. Oparil, A. Cheung, W. Ambrosius, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Device-Based Therapy for Drug-Resistant Hypertension: An Update

V. Papademetriou, Ping Li, M. Nader, 2016, Current Hypertension Reports.

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial

C. Tsioufis, I. Meredith, V. Papademetriou, 2013, European heart journal.

Achieving Renal Denervation: Catheter-Based and Surgical Management for Neural Ablation in the Management of Hypertension

V. Papademetriou, N. Sodha, G. Trachiotis, 2012, Innovations.

Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension

S. Douma, V. Papademetriou, C. Zamboulis, 2011, International journal of hypertension.

Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions

V. Papademetriou, M. Doumas, Daqing Guo, 2009 .

A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure

J. Myers, V. Papademetriou, P. Kokkinos, 2009, Blood pressure.

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial

James R. Powell, M. Rocco, D. Reboussin, 2017, Diabetes Care.

Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).

M. Nieminen, R. Devereux, J. Bella, 2004, The American journal of cardiology.

Long-term effects of multielectrode renal denervation on cardiac adaptations in resistant hypertensive patients with left ventricular hypertrophy

C. Tsioufis, V. Papademetriou, D. Tousoulis, 2016, Journal of Human Hypertension.

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

S. Pocock, N. Chapman, K. Kario, 2018, The Lancet.

Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy

G. Grassi, C. Tsioufis, C. Stefanadis, 2015, Journal of hypertension.

Relationship of ambulatory arterial stiffness index with blood pressure response to exercise in the early stages of hypertension

C. Tsioufis, C. Stefanadis, A. Michaelides, 2010, Blood pressure monitoring.

Masked Hypertension and Atherogenesis: The Impact of Apelin and Relaxin Plasma Levels

C. Tsioufis, V. Papademetriou, D. Perrea, 2013, Journal of clinical hypertension.

Left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy and mild valvular insufficiency (The LIFE Study)

V. Papademetriou, J. Kontos, 2004 .

Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.

M. Nieminen, R. Devereux, G. de Simone, 2001, American heart journal.

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)

M. Nieminen, R. Devereux, J. Bella, 2000 .

Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up

C. Tsioufis, C. Stefanadis, J. Floras, 2013, Journal of hypertension.

Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.

D. Panagiotakos, J. Myers, V. Papademetriou, 2014, American journal of hypertension.

Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

R. Devereux, J. Bella, V. Palmieri, 2002, Circulation.

Exercise blood pressure response and left ventricular hypertrophy.

E. Freis, V. Papademetriou, R. Fletcher, 1989, American journal of hypertension.

Effect of Intensive and Standard Clinic‐Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT

P. Whelton, Mahboob Rahman, W. Cushman, 2019, Journal of the American Heart Association.

Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.

I. Kallikazaros, C. Tsioufis, I. Meredith, 2015, International journal of cardiology.

Hypertension Management in African Americans: The AASK and Other Landmark Trial Application

V. Papademetriou, Ping Li, Samir S. Patel, 2018, Management of Hypertension.

Thiazide therapy is not a cause of arrhythmia in patients with systemic hypertension.

E. Freis, V. Papademetriou, R. Fletcher, 1988, Archives of internal medicine.

Cardiovascular Risk Assessment and Triptans

V. Papademetriou, 2004, Headache.

Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.

M. Banach, C. Morgan, S. Anker, 2017, International journal of cardiology.

Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT.

M. Rocco, D. Berlowitz, B. Freedman, 2020, Clinical journal of the American Society of Nephrology : CJASN.

The clinical value of automated office blood pressure: What is the latest evidence on attended vs unattended automated readings in clinical practice?

V. Papademetriou, C. Geladari, E. Andreadis, 2018, Journal of clinical hypertension.

Cardiovascular Outcomes in Action to Control Cardiovascular Risk in Diabetes: Impact of Blood Pressure Level and Presence of Kidney Disease

W. Cushman, W. Applegate, C. Tsioufis, 2016, American Journal of Nephrology.

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.

H. Gerstein, J. Probstfield, V. Papademetriou, 2017, The American journal of medicine.

Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta‐analysis of randomized, sham‐controlled, catheter‐based trials

C. Tsioufis, V. Papademetriou, M. Doumas, 2020, Journal of clinical hypertension.

Effects of aerobic training on exaggerated blood pressure response to exercise in African-Americans with severe systemic hypertension treated with indapamide +/- verapamil +/- enalapril.

V. Papademetriou, P. Kokkinos, R. Fletcher, 1997, The American journal of cardiology.

Echocardiographic Wall Motion Abnormalities in Hypertensive Patients With Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study

J. Gardin, M. Nieminen, P. Okin, 2003, Hypertension.

Views and Perspectives Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT 1B/1D Agonists) in the Acute Treatment of Migraine

S. Hahn, R. Lipton, S. Silberstein, 2004 .

The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?

C. Tsioufis, V. Papademetriou, E. Geladari, 2018, Current vascular pharmacology.

Aspirin Under Fire: Aspirin Use in the Primary Prevention of Coronary Heart Disease

Michael G. Miller, V. Papademetriou, B. D. Lucas, 2005, Pharmacotherapy.

Labile hypertension: a new disease or a variability phenomenon?

V. Papademetriou, E. Sanidas, K. Tsioufis, 2019, Journal of Human Hypertension.

The Role of Angiogenesis Inhibitors in Hypertension: Following “Ariadne’s Thread”

V. Papademetriou, E. Sanidas, D. Papadopoulos, 2018, American journal of hypertension.

Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?

C. Tsioufis, V. Papademetriou, M. Doumas, 2017, Current Treatment Options in Cardiovascular Medicine.

Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension?

C. Tsioufis, V. Papademetriou, D. Tousoulis, 2017, Current vascular pharmacology.

Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension.

M S Nieminen, M. Nieminen, P. Okin, 2000, Journal of hypertension.

Hypertension crisis

V. Papademetriou, D. Papadopoulos, I. Mourouzis, 2010, Blood pressure.

Selection of antihypertensive therapy for patients with hypertensive renal disease.

V. Papademetriou, 2001, JAMA.

Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. The LIFE Study.

M. Nieminen, P. Okin, R. Devereux, 2007, American Journal of Hypertension.

Tolerability profile of tasosartan, a long-acting angiotensin II AT1 receptor blocker, in the treatment of patients with essential hypertension

S. Oparil, V. Papademetriou, A. Gradman, 1997 .

Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study

C. Tsioufis, C. Stefanadis, V. Papademetriou, 2009, Journal of hypertension.

Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study.

M. Nieminen, R. Devereux, J. Bella, 2008, American journal of hypertension.

P-246: Left ventricular mass changes in patients with isolated systolic or combined hypertension and echocardiographic left ventricular hypertrophy: the life study

V. Palmieri, V. Papademetriou, M. Olsen, 2003 .

Abstract 2751: An Implantable Carotid Sinus Baroreflex Activating System for Drug-Resistant Hypertension: Interim Chronic Efficacy Results from the Multi-Center Rheos Feasibility Trial

R. Kieval, R. Cody, V. Papademetriou, 2006 .

Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics

V. Papademetriou, 2002 .

Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial).

P. Whelton, M. Rocco, S. Oparil, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes

A. Cheung, C. Yuan, M. Conroy, 2021, BMC Nephrology.

Effects of diuretic therapy and exercise-related arrhythmias in systemic hypertension.

E D Freis, R D Fletcher, E. Freis, 1989, The American journal of cardiology.

Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial

Lawrence A Leiter, P. O’Connor, R. Byington, 2014, Diabetes Care.

Hypertension in pregnancy: unanswered questions.

V. Papademetriou, C. Papadopoulos, K. Stavropoulos, 2021, Current pharmaceutical design.

Antihypertensive therapy and quality of life. Influence of blood pressure reduction, adverse events, and prior antihypertensive therapy.

V. Papademetriou, M. Weir, M. Weber, 1996, American journal of hypertension.

Olmesartan worsening known thrombocytopenia. A rare side effect of antihypertensive drugs.

V. Papademetriou, E. Sanidas, D. Papadopoulos, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Morning Surge and Peak Morning Ambulatory Blood Pressure Versus Automated Office Blood Pressure in Predicting Cardiovascular Disease

V. Papademetriou, G. Kolyvas, C. Geladari, 2019, High Blood Pressure & Cardiovascular Prevention.

Management of Hypertension

E. Freis, V. Papademetriou, C. Geladari, 2019, Springer International Publishing.

Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.

V. Papademetriou, M. Lefkowitz, N. Kaplan, 1993, The American journal of medicine.

Effects of Intensive BP Control in CKD.

P. Whelton, K. Sink, M. Rocco, 2017, Journal of the American Society of Nephrology : JASN.

Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

S. Pocock, N. Chapman, K. Kario, 2018, The Lancet.

Renal Denervation for Drug-Resistant Hypertension: There Is Still Hope.

V. Papademetriou, 2015, Cardiovascular revascularization medicine : including molecular interventions.

Arterial Stiffness and Emerging Biomarkers

V. Papademetriou, V. Athyros, A. Karagiannis, 2015, Angiology.

Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial".

Deepak L. Bhatt, K. Shunk, B. Rangan, 2020, Circulation. Cardiovascular interventions.

Determinants of pulse wave velocity index and potential implementations

V. Papademetriou, K. Imprialos, K. Stavropoulos, 2019, Journal of clinical hypertension.

Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

M. Nieminen, R. Devereux, V. Papademetriou, 2004, Circulation.

1009-166 Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE trial)

M. Nieminen, R. Devereux, V. Papademetriou, 2004 .

Exercise Capacity and Progression From Prehypertension to Hypertension

D. Panagiotakos, V. Papademetriou, P. Kokkinos, 2012, Hypertension.

Aggressive blood pressure control and stroke prevention: role of calcium channel blockers

V. Papademetriou, D. Papadopoulos, 2008, Journal of hypertension.

V. Papademetriou, E. Geladari, H. Moore, 2017, Cardiovascular revascularization medicine : including molecular interventions.

Unintentional overestimation of an expected antihypertensive effect in drug and device trials: mechanisms and solutions.

Deepak L. Bhatt, D. Kandzari, J. Davies, 2014, International journal of cardiology.

Attended Versus Unattended Automated Office Blood Pressure: A Systematic Review and Meta-analysis

V. Papademetriou, C. Geladari, E. Andreadis, 2019, High Blood Pressure & Cardiovascular Prevention.

Apelin and Relaxin Plasma Levels in Young Healthy Offspring of Patients With Essential Hypertension

C. Tsioufis, V. Papademetriou, D. Perrea, 2014, Journal of clinical hypertension.

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial

James R. Powell, M. Rocco, D. Reboussin, 2017, Diabetes Care.

Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.

R. Wilensky, J. Stehli, K. Kario, 2023, Journal of the American College of Cardiology.

Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom).

C. Tsioufis, V. Papademetriou, M. Doumas, 2014, Circulation research.

Should Target Organ Damage Become a Therapeutic Target?

V. Papademetriou, 2013, Journal of clinical hypertension.

Expertise: No Longer a Sine Qua Non for Guideline Authors?

K. Kario, G. Parati, G. Mancia, 2017, Hypertension.

Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension.

V. Papademetriou, D. Weidler, J. Wallin, 1991, The American journal of medicine.

Improvement in All‐Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug‐Resistant Hypertension

V. Papademetriou, P. Kokkinos, C. Faselis, 2016, Journal of clinical hypertension.

Screening for Primary Aldosteronism: Whom and How?

V. Papademetriou, V. Athyros, M. Doumas, 2015, Journal of clinical hypertension.

Research Article Physicians' Perceptions and Adherence to Guidelines for the Management of Hypertension: a National, Multicentre, Prospective Study

V. Papademetriou, N. Maniadakis, G. Kourlaba, 2022 .

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

J. Probstfield, V. Papademetriou, C. Ford, 2002 .

MANAGEMENT OF SYSTOLIC HEART FAILURE

V. Papademetriou, M. Dunlap, 2003 .

The Reply.

V. Papademetriou, 2018, The American journal of medicine.

1009-195 The effect of seasonal variation of blood pressure when analyzing improvement and treating large groups of hypertensive patients

Ronald E. Jones, V. Papademetriou, C. McManus, 2004 .

Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study

J. Gardin, M. Nieminen, R. Devereux, 2008, Journal of hypertension.